Show simple item record

Best treatment option for infantile chronic myeloid leukemia patients: imatinib or hematopoietic stem cell transplantation?

dc.contributor.authorAYDOGAN, Gülcan
dc.contributor.authorAKCAY, A
dc.contributor.authorERBEY, F
dc.contributor.authorSALCIOGLU, Z
dc.contributor.authorAKICI, F
dc.contributor.authorOZTURK, G
dc.contributor.authorTugcu, Deniz
dc.date.accessioned2021-03-03T11:34:58Z
dc.date.available2021-03-03T11:34:58Z
dc.identifier.citationAKCAY A., Tugcu D., AYDOGAN G., ERBEY F., SALCIOGLU Z., AKICI F., OZTURK G., "Best treatment option for infantile chronic myeloid leukemia patients: imatinib or hematopoietic stem cell transplantation?", Pediatric transplantation, cilt.18, ss.316-7, 2014
dc.identifier.issn1397-3142
dc.identifier.otherav_28bdd98d-5e75-4ad2-a392-c82490942c38
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/32236
dc.identifier.urihttps://doi.org/10.1111/petr.12234
dc.language.isoeng
dc.titleBest treatment option for infantile chronic myeloid leukemia patients: imatinib or hematopoietic stem cell transplantation?
dc.typeMakale
dc.relation.journalPediatric transplantation
dc.contributor.department, ,
dc.identifier.volume18
dc.identifier.startpage316
dc.identifier.endpage7
dc.contributor.firstauthorID180820


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record